---
schema_version: "secwatch.filing_event.v1"
accession: "0000947871-22-000962"
form_type: "8-K"
ticker: "CVS"
cik: "0000064803"
company_name: "CVS HEALTH Corp"
filed_at: "2022-09-13T23:59:59+00:00"
generated_at: "2026-06-23T10:29:14.374578+00:00"
event_type: "leadership"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# CVS Health elects Jeffrey R. Balser, MD, PhD to Board of Directors

## Summary
- Dr. Balser has served as President and CEO of Vanderbilt University Medical Center since 2009.
- He guided VUMC's $1.2 billion public debt issuance and legal separation from Vanderbilt University.
- Balser was appointed to the Board's Medical Affairs Committee and deemed independent under NYSE rules.
- His compensation matches other non-employee directors, prorated from September 12, 2022.

## SEC filing metadata
- accession: 0000947871-22-000962
- form_type: 8-K
- ticker: CVS
- cik: 0000064803
- company_name: CVS HEALTH Corp
- filed_at: 2022-09-13T23:59:59+00:00
- event_type: leadership
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02
- EDGAR index: https://www.sec.gov/Archives/edgar/data/64803/000094787122000962/0000947871-22-000962-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/64803/000094787122000962/ss1324378_8k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000947871-22-000962
- JSON: https://secwatch.observer/filing/0000947871-22-000962.json
- Plain text: https://secwatch.observer/filing/0000947871-22-000962.txt

## Key facts
- Executive change
  Jeffrey R. Balser was elected as Director at CVS HEALTH Corp.
  - Action: elected
  - Role: Director
  source text: Effective September 12, 2022, the Board of Directors (the “Board”) of CVS Health Corporation (“CVS Health” or the “Company”) elected Jeffrey R. Balser, M.D., Ph.D., to serve on the Board.
  evidence_url: https://www.sec.gov/Archives/edgar/data/64803/000094787122000962/0000947871-22-000962-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.